TAXOTERE 160 mg/8 ml, concentrate for solution for infusion bottle, 8 ml
Active ingredients: Docetaxel, Docetaxel trihydrate
Commercialized according to BDPMDispensing in France: Prescription only
Concentrate for solution for infusionbottle, 8 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TAXOTERE 160 mg/8 ml, solution à diluer pour perfusion
- Pharmaceutical form
- solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre de 8 ml
- Marketing authorisation holder
- SANOFI WINTHROP INDUSTRIE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 21 Mar 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60509781CIP75775674CIP133400957756741Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DOCÉTAXEL TRIHYDRATÉsolution | — | SA |
| DOCÉTAXEL ANHYDREsolution | 160 mg · un flacon | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.